These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3128939)

  • 1. The immunosuppressive fraction isolated from uremic ultrafiltrates: attempted characterization of the mechanism of action.
    Navarro J; Grossetête MC; Touraine JL; Traeger J
    Adv Exp Med Biol; 1987; 223():157-60. PubMed ID: 3128939
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation of an immunosuppressive fraction from uremic ultrafiltrates.
    Navarro J; Grossetête MC; Touraine JL; Traeger J
    Adv Exp Med Biol; 1987; 223():161-4. PubMed ID: 3447433
    [No Abstract]   [Full Text] [Related]  

  • 3. Uremic serum inhibits monocyte-dependent, but not interleukin-2-dependent steps of T cell proliferation.
    Dumann H; Meuer SC; Köhler H
    Nephron; 1990; 56(2):162-5. PubMed ID: 2243571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune deficiency of the uremic patient.
    Chatenoud L; Herbelin A; Beaurain G; Descamps-Latscha B
    Adv Nephrol Necker Hosp; 1990; 19():259-74. PubMed ID: 2105582
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological studies in uremic and kidney transplanted patients.
    Langhoff E
    Dan Med Bull; 1989 Apr; 36(2):160-75. PubMed ID: 2651030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunosuppressive factor(s) in uremic sera.
    Kamata K; Okubo M; Marumo F
    Proc Clin Dial Transplant Forum; 1980; 10():47-50. PubMed ID: 6981113
    [No Abstract]   [Full Text] [Related]  

  • 7. Binding of organic acids to surface receptors of lymphocytes as an immunosuppressive mechanism in uremia.
    Sanaka T; Hayasaka Y; Kawashima Y; Takuma T; Sugino N; Ota K; Gulyassy PF
    Adv Exp Med Biol; 1987; 223():165-9. PubMed ID: 3502315
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W; Reed JC; Nowell PC; Kamoun M
    J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to mouse hepatitis virus strain 3 in BALB/cJ mice: failure of immune cell proliferation and interleukin 2 production.
    Dindzans VJ; Zimmerman B; Sherker A; Levy GA
    Adv Exp Med Biol; 1987; 218():411-20. PubMed ID: 2829553
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolation of an immunosuppressive fraction in ultrafiltrate from uremic sera.
    Navarro J; Grossetete MC; Defrasne A; Touraine JL; Traeger J
    Nephron; 1985; 40(4):396-400. PubMed ID: 4022207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of receptors for interleukin 2 requires T cell Ag:Ia receptor crosslinking and interleukin 1.
    Kaye J; Janeway CA
    Lymphokine Res; 1984; 3(4):175-82. PubMed ID: 6436584
    [No Abstract]   [Full Text] [Related]  

  • 12. Interleukins and the immune system 1.
    O'Garra A
    Lancet; 1989 Apr; 1(8644):943-7. PubMed ID: 2565429
    [No Abstract]   [Full Text] [Related]  

  • 13. Spontaneous production of a suppressor factor by a human macrophage-like cell line U937. II. Suppression of antigen- and mitogen-induced blastogenesis, IL 2 production and IL 2 receptor expression in T lymphocytes.
    Fujiwara H; Toossi Z; Ohnishi K; Edmonds K; Ellner JJ
    J Immunol; 1987 Jan; 138(1):197-203. PubMed ID: 3097146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of uremic middle molecules on in vitro stimulated lymphocytes and interleukin-2 production.
    Severini G; Diana L; Di Giovannandrea R; Sagliaschi G
    ASAIO J; 1996; 42(1):64-7. PubMed ID: 8808461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation in autologous mixed lymphocyte reactions, expression of HLA-class II antigen and serum immunomodulatory activity in patients with renal insufficiency on chronic dialysis.
    Puppo F; Gurreri G; Pattarini R; Ranise A; Indiveri F
    Allergol Immunopathol (Madr); 1991; 19(4):167-73. PubMed ID: 1840170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of human lymphocyte proliferation by soluble factors.
    Maizel AL; Lachman LB
    Lab Invest; 1984 Apr; 50(4):369-77. PubMed ID: 6423891
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of cyclosporin A on the immune system.
    Shevach EM
    Annu Rev Immunol; 1985; 3():397-423. PubMed ID: 3933532
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological properties of interleukins.
    Bendtzen K
    Allergy; 1983 May; 38(4):219-26. PubMed ID: 6307076
    [No Abstract]   [Full Text] [Related]  

  • 19. The glioblastoma-derived T cell suppressor factor/transforming growth factor-beta 2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor.
    Siepl C; Bodmer S; Frei K; MacDonald HR; De Martin R; Hofer E; Fontana A
    Eur J Immunol; 1988 Apr; 18(4):593-600. PubMed ID: 2452745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytokines and receptors--their functions, structure and cloning of code genes. Interleukin-2 and receptor].
    Tagaya Y; Yodoi J
    Nihon Rinsho; 1988 May; 46(5):1002-7. PubMed ID: 3137376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.